Actively Recruiting

Phase Not Applicable
Age: 18Years - 85Years
All Genders
NCT06916741

Effect of a Sacral Lift on Femoral Vein Size and Exposure

Led by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) · Updated on 2026-03-16

35

Participants Needed

1

Research Sites

123 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to learn if a sacral lift can improve femoral vein size and exposure, which may be clinically helpful during femoral vein cannulation among emergency department patients. The main questions it aims to answer are: Does a sacral lift increase femoral vein size compared to no sacral lift in both straight and frog-leg positions? Does a sacral lift improve femoral vein exposure (reduce overlap by the femoral artery) compared to no sacral lift in both straight and frog-leg positions? Researchers will compare femoral vein size and exposure measurements with and without a sacral lift in both straight and frog-leg leg positions to see if the sacral lift improves vein size and reduces artery overlap. Participants will: Undergo femoral vein ultrasound scans. Maintain a straight leg position with and without a sacral lift. Maintain a frog-leg position with and without a sacral lift.

CONDITIONS

Official Title

Effect of a Sacral Lift on Femoral Vein Size and Exposure

Who Can Participate

Age: 18Years - 85Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult emergency department patients
Not Eligible

You will not qualify if you...

  • Younger than 18 or older than 85 years
  • History of deep venous thrombosis (DVT) or May-Thurner syndrome
  • History of lower extremity vein harvesting
  • History of arterial or venous surgery of the lower leg, such as peripheral arterial stent placement or sclerotherapy of varicose veins
  • Peripheral vascular disease
  • Medical conditions preventing safe lying supine or safe hip abduction and external rotation (e.g., hip fracture)
  • Femoral vessels not clearly visible with ultrasound linear transducer
  • Femoral vein not compressible on ultrasound indicating DVT
  • Vulnerable populations including pregnant women and those unable to consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Saint Vincent Hospital

Erie, Pennsylvania, United States, 16544

Actively Recruiting

Loading map...

Research Team

D

Dhimitri Nikolla, DO, MS, FACEP, FACOEP

CONTACT

A

AHN Clinical Trials Contact

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

DIAGNOSTIC

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here